Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases

被引:4
|
作者
Netzahualcoyotzi, Citlalli [1 ,2 ,5 ]
Santillan-Cigales, Juan Jair [1 ]
Adalid-Peralta, Laura Virginia [2 ]
Velasco, Ivan [1 ,2 ,3 ,4 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City, Mexico
[2] Inst Nacl Neurol & Neurocirugia Manuel Velasco Sua, Lab Reprogramac Celular, Mexico City, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, Mexico
[4] Inst Nacl Neurol & Neurocirugia Manuel Velasco Sua, Lab Reprogramac Celular, Mexico City 14269, Mexico
[5] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Farmacol, Mexico City, Mexico
关键词
Alzheimer's disease; blood-brain barrier; leukocytes; neuroimmunology; neurovascular unit; Parkinson's disease; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PROTEIN; CD8; T-CELLS; ALZHEIMERS-DISEASE; MAST-CELLS; MOUSE MODEL; IFN-GAMMA; BARRIER PERMEABILITY; NEUROVASCULAR UNIT; MICROGLIAL ACTIVATION;
D O I
10.1111/jnc.16106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neurovascular unit, composed of vascular endothelium, vascular smooth muscle, extracellular matrix components, pericytes, astrocytes, microglia, and neurons, allows the highly regulated exchange of molecules and the limited trafficking of cells to the brain through coordinated signaling activity. The passage of peripheral immune cells to the brain parenchyma is observed when there is clear damage to the barriers of this neurovascular unit, as occurs in traumatic brain injury. The possibility of leukocyte infiltration to the brain in neurodegenerative conditions has been proposed. In this review, we focus on describing the evidence for peripheral immune cell infiltration to the brain in the two most frequent neurodegenerative diseases: Alzheimer's and Parkinson's diseases. In particular, we address the mechanisms that promote the passage of these cells into the brain under such pathological conditions. We also discuss the relevance of the resulting cellular interactions, which provide evidence that the presence of peripheral immune cells in the brain is a key point in these neurodegenerative diseases. The disruption of the neurovascular unit and the infiltration of the peripheral immune cells into the central nervous system are hallmarks of neurodegenerative diseases. However, so far, the participation of infiltrating cells in the progression of these diseases has not been completely defined. In this work, we gather the evidence that exists until now which proposes the key events involved in the pathogenesis of the two main neurodegenerative diseases: Alzheimer's and Parkinson's diseases. We detail the alterations in the components that typically keep the neurovascular unit semi-permeable to the cellular interactions that promote a self-perpetuating cycle of inflammation.image
引用
收藏
页码:2316 / 2334
页数:19
相关论文
共 50 条
  • [31] Caregivers' attitudes toward blood-based biomarker testing for Alzheimer's disease
    Bolsewig, Katharina
    Blok, Hester
    Willemse, Eline A. J.
    Zwaaftink, Rob B. M. Groot
    Kooistra, Minke
    Smets, Ellen M. A.
    Teunissen, Charlotte E.
    Visser, Leonie N. C.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2024, 16 (01)
  • [32] Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach
    Marras, Connie
    Fereshtehnejad, Seyed-Mohammad
    Berg, Daniela
    Bohnen, Nicolaas I.
    Dujardin, Kathy
    Erro, Roberto
    Espay, Alberto J.
    Halliday, Glenda
    Van Hilten, Jacobus J.
    Hu, Michele T.
    Jeon, Beomseok
    Klein, Christine
    Leentjens, Albert F. G.
    Mollenhauer, Brit
    Postuma, Ronald B.
    Rodriguez-Violante, Mayela
    Simuni, Tanya
    Weintraub, Daniel
    Lawton, Michael
    Mestre, Tiago A.
    MOVEMENT DISORDERS, 2024, 39 (03) : 462 - 471
  • [33] Sex differences in risk factors, burden, and outcomes of cerebrovascular disease in Alzheimer's disease populations
    Morrison, Cassandra
    Dadar, Mahsa
    Collins, Donald Louis
    ALZHEIMERS & DEMENTIA, 2024, 20 (01) : 34 - 46
  • [34] A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease
    Damier, Philippe
    Degos, Bertrand
    Castelonovo, Giovanni
    Anheim, Mathieu
    Benatru, Isabelle
    Carriere, Nicolas
    Colin, Olivier
    Defebvre, Luc
    Deverdal, Marie
    Eusebio, Alexandre
    Ferrier, Vanessa
    Giordana, Caroline
    Houeto, Jean-Luc
    Le Dily, Severine
    Mongin, Marie
    Thiriez, Claire
    Tranchant, Christine
    Ravel, Denis
    Corvol, Jean-Christophe
    Rascol, Olivier
    Ben Ari, Yehezkel
    MOVEMENT DISORDERS, 2024, 39 (03) : 618 - 622
  • [35] Exploring Parkinson's disease prevalence in regional, rural and remote Australia: A systematic scoping review
    Fealy, Shanna
    Logan, Patricia A.
    Micalos, Peter S.
    Rossiter, Rachel
    Jones, Donovan
    Irwin, Pauletta
    Schwebel, Deborah
    Carroll, Vincent
    Wong, Alfred
    Fung, Victor S. C.
    Morales-Briceno, Hugo
    Bramble, Marguerite
    AUSTRALIAN JOURNAL OF RURAL HEALTH, 2023, 31 (06) : 1156 - 1167
  • [36] Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies
    Azzini, Elena
    Pena-Corona, Sheila I.
    Hernandez-Parra, Hector
    Chandran, Deepak
    Saleena, Lejaniya Abdul Kalam
    Sawikr, Yousef
    Peluso, Ilaria
    Dhumal, Sangram
    Kumar, Manoj
    Leyva-Gomez, Gerardo
    Martorell, Miquel
    Sharifi-Rad, Javad
    Calina, Daniela
    PHYTOTHERAPY RESEARCH, 2024, 38 (06) : 3169 - 3189
  • [37] Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E?4 allele
    Ji, Xiao-Yu
    Peng, Xin-Yuan
    Tang, Hai-Liang
    Pan, Hui
    Wang, Wei-Tang
    Wu, Jie
    Chen, Jian
    Wei, Nai-Li
    BRAIN PATHOLOGY, 2023,
  • [38] Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease
    Ahmed, Tanvir
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 59 (11) : 2915 - 2954
  • [39] Anxiety in Alzheimer's disease rats is independent of memory and impacted by genotype, age, sex, and exercise
    Lopez, Danielle C.
    White, Zachary J.
    Hall, Stephanie E.
    ALZHEIMERS & DEMENTIA, 2024, 20 (05) : 3543 - 3550
  • [40] Discriminant accuracy of standing balance tests for level of gait dependency in hospitalized patients with Alzheimer's disease
    Nakagawa, Keita
    Kanai, Shusaku
    Kitakaze, Sosuke
    Okamura, Hitoshi
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2024, 53 (03) : 135 - 142